1. Home
  2. MFIC vs INMD Comparison

MFIC vs INMD Comparison

Compare MFIC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFIC
  • INMD
  • Stock Information
  • Founded
  • MFIC 2004
  • INMD 2008
  • Country
  • MFIC United States
  • INMD Israel
  • Employees
  • MFIC N/A
  • INMD N/A
  • Industry
  • MFIC Finance/Investors Services
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MFIC Finance
  • INMD Health Care
  • Exchange
  • MFIC Nasdaq
  • INMD Nasdaq
  • Market Cap
  • MFIC 1.3B
  • INMD 1.5B
  • IPO Year
  • MFIC 2004
  • INMD 2019
  • Fundamental
  • Price
  • MFIC $13.49
  • INMD $16.79
  • Analyst Decision
  • MFIC Buy
  • INMD Buy
  • Analyst Count
  • MFIC 8
  • INMD 6
  • Target Price
  • MFIC $14.50
  • INMD $22.40
  • AVG Volume (30 Days)
  • MFIC 380.7K
  • INMD 947.3K
  • Earning Date
  • MFIC 02-25-2025
  • INMD 02-04-2025
  • Dividend Yield
  • MFIC 11.27%
  • INMD N/A
  • EPS Growth
  • MFIC 14.94
  • INMD N/A
  • EPS
  • MFIC 1.53
  • INMD 1.84
  • Revenue
  • MFIC $291,576,000.00
  • INMD $423,746,000.00
  • Revenue This Year
  • MFIC $12.92
  • INMD N/A
  • Revenue Next Year
  • MFIC $17.11
  • INMD $2.48
  • P/E Ratio
  • MFIC $8.84
  • INMD $9.14
  • Revenue Growth
  • MFIC 8.84
  • INMD N/A
  • 52 Week Low
  • MFIC $12.26
  • INMD $14.87
  • 52 Week High
  • MFIC $16.36
  • INMD $26.80
  • Technical
  • Relative Strength Index (RSI)
  • MFIC 49.97
  • INMD 46.02
  • Support Level
  • MFIC $13.04
  • INMD $15.43
  • Resistance Level
  • MFIC $13.73
  • INMD $16.80
  • Average True Range (ATR)
  • MFIC 0.18
  • INMD 0.50
  • MACD
  • MFIC 0.01
  • INMD 0.03
  • Stochastic Oscillator
  • MFIC 65.22
  • INMD 67.33

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: